Tesamorelin is a synthetic peptide analog of human growth hormone-releasing factor (GRF), also known as growth hormone-releasing hormone (GHRH). It consists of a modified 44-amino-acid peptide sequence designed for research involving peptide structure, receptor interactions, and growth hormone-related signaling pathways.
Tesamorelin differs structurally from native human GRF through modification of its N-terminal region. Its defined molecular structure makes it a useful reference compound in biochemical, peptide-characterization, receptor, and molecular signaling research.
This Tesamorelin product is supplied as a research material for controlled laboratory and analytical applications.